G Medical Innovations Holdings, Ltd. (NASDAQ: GMVD) is an Israeli healthcare company, which is focused on the research and development of next-gen mHealth, telemedicine solutions, and monitoring services. Shares of the digital health company are skyrocketing 85% through early trading on Monday, January 30, 2023. Over the past three months, G Medical Innovations has seen average daily volume of 392,370 shares. However, volume of 18.5 million shares or dollar volume of around $101.8 million, has already exchanged hands through early trading.
Shares of G Medical Innovations are surging after the company announced the receipt of a patent issuance notification from the United States Patent and Trademark Office (USPTO) for its vital sign monitoring products sold in the USA. The patent titled, “Method and System for Vital Signs Monitoring with Earpiece,” is estimated to be officially issued on or around February 7, 2023 and will cover G Medical Innovations’ monitoring system that is being developed for “multiple sensing mechanisms to be used on different body locations.” The company’s vital sign monitoring system is being designed to help healthcare providers with greater versatility in being to monitor a patient’s condition in an in-patient or out-patient setting.
G Medical Innovations was previously awarded two patents in December 2022, which allows the company to continue securing its innovations and strengthen its position in the market. Management believes the recent patents provide the company with significant advantages over its competitors.
In total, the company holds six patents for its product (four in the U.S. and two in China). Management also notes that there are currently three additional patents that are pending approval in the United States.
Disclosure: No position. Spotlight Growth has no relationships with any of the companies mentioned in this article and did not receive payment in any form for its creation. This is an opinion article and is not meant to be financial advise. We are not broker-dealers or investment professionals. Please conduct your own due diligence. For more information on our disclosures, please visit: https://spotlightgrowth.com/disclosures/